Position in CYTK
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$18,594,594
+$2,314,885 QoQ
Shares Held
282,121
+10.1% QoQ
Ownership
0.203%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 0%
Shared 81%
None 19%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026JANUS HENDERSON GROUP PLC holds $15,213,180,190 across 182 Biotechnology names. CYTK ranks #76 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,541,732 | $1,856,099,791 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
3,458,863 | $1,114,411,067 | |
| 3 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
2,018,647 | $1,056,701,142 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
13,179,013 | $978,673,503 | |
| 5 | PCVX |
Vaxcyte, Inc.
|
16,575,875 | $963,224,094 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,131,527 | $951,812,064 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
9,766,496 | $949,791,733 | |
| 8 | MIRM |
Mirum Pharmaceuticals, Inc.
|
6,945,813 | $641,654,204 |
All Filings in CYTK
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $18,594,594 | 282,121 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $16,279,709 | 256,212 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,724,037 | 49,564 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,637,594 | 49,564 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $42,486,697 | 1,057,146 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $48,188,574 | 1,024,417 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $60,394,224 | 1,143,830 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $52,897,504 | 976,329 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $55,903,749 | 797,372 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $214,436,132 | 2,568,405 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $73,453,383 | 2,493,326 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $68,361,700 | 2,095,699 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $55,376,531 | 1,573,644 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $7,969,470 | 173,930 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $724,957 | 14,963 | Shares | Defined | 2023-01-13 | |
| 2022-06-30 | $587,070 | 14,942 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $550,235 | 14,948 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $681,147 | 14,944 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $265,047 | 7,416 | Shares | Defined | 2021-11-16 | |
| No filing history on record for this holder in this stock. | ||||||